PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
29407880-6	2018	Resveratrol treatment decreased serum Ang II level and the aortic expression of prorenin receptor (PRR) and angiotensin converting enzyme (ACE), and increased serum Ang-(1-7) level and the expression of ACE2, Ang II type 2 receptor (AT2R), and Mas receptor (MasR).	Resveratrol	0-11	angiotensin I converting enzyme (peptidyl-dipeptidase A) 1	Mus musculus	108-137	
34539617-6	2021	In addition, 16S rRNA sequencing results showed that RSV supplementation increased the richness indices of intestinal microbiota (Chao, ACE) and shaped the composition of intestinal microbiota (e.g., increased beta-diversity of intestinal microbiota community).	Resveratrol	53-56	angiotensin I converting enzyme (peptidyl-dipeptidase A) 1	Mus musculus	136-139	
29407880-6	2018	Resveratrol treatment decreased serum Ang II level and the aortic expression of prorenin receptor (PRR) and angiotensin converting enzyme (ACE), and increased serum Ang-(1-7) level and the expression of ACE2, Ang II type 2 receptor (AT2R), and Mas receptor (MasR).	Resveratrol	0-11	angiotensin I converting enzyme (peptidyl-dipeptidase A) 1	Mus musculus	139-142	
29407880-9	2018	CONCLUSIONS: Resveratrol protects against arterial aging and this effect is associated with reduced activity of the PRR-ACE-Ang II axis and stimulation of the ACE2-Ang-(1-7)-ATR2-MasR axis.	Resveratrol	13-24	angiotensin I converting enzyme (peptidyl-dipeptidase A) 1	Mus musculus	120-123	
24642355-5	2014	The RT-PCR analysis revealed decreased expression of ACE and an increase of ACE2 [Ang-(1-7) marker] in group treated with resveratrol and also an increased expression of SIRT1 in groups that received Ang-(1-7).	Resveratrol	122-133	angiotensin I converting enzyme (peptidyl-dipeptidase A) 1	Mus musculus	53-56